Merck & Co., Inc. (MRK) reported profit for the fourth quarter that increased 29 percent from last year, reflecting higher sales for Keytruda. Quarterly sales increased by 8 percent. The company plans to spin off its Women's Health, Trusted Legacy Brands and Biosimilar Products businesses into a separate publicly traded company.
from RTT - Earnings https://ift.tt/31qYmwR
via IFTTT
No comments:
Post a Comment